← SynDRA
SYN0722913
SynDRA canonical compound SYN0722913 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CASP3 | MAP3K5 |
|---|
| Mechanism of action | caspase inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ATAD5
- EHMT2
- GMNN
- KDM4A
- PKM
- POLH
- POLI
- RECQL
- RGS4
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- NQDI 1
- MFCD03265970
- MLS000715851
- SMR000277368
- F1414-1232
- Oprea1_384256
- Oprea1_559557
- NQDI-1?
- IFLab1_005737
- orb1304540
- SCHEMBL17949560
- BDBM32315
- cid_5522952
- EX-A820
- GLXC-07623
- HMS1428E17
- HMS2646I12
- SMSSF-0040646
- s8289
- STK793109
- STL514199
- AKOS000594203
- AKOS037491857
- CCG-267688
- CS-5290
- NQDI-1, >=98% (HPLC)
- IDI1_011140
- NCGC00386645-03
- AC-31492
- AS-55871
- HY-19566
- DS-015873
- ST4083161
- F31217
- AB00686019-01
- AQ-390/42425636
- BRD-K61918008-001-07-1
Look up SYN0722913 in the interactive SynDRA portal →